HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.

AuthorsMichelle Prickett, Manu Jain
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 186 Issue 12 Pg. 1310-1 (Dec 15 2012) ISSN: 1535-4970 [Electronic] United States
PMID23250504 (Publication Type: Letter)
Chemical References
  • Aminoglycosides
  • Anti-Bacterial Agents
  • beta-Lactams
Topics
  • Administration, Intravenous
  • Aminoglycosides (adverse effects)
  • Anti-Bacterial Agents (therapeutic use)
  • Contraindications
  • Cystic Fibrosis (complications, drug therapy, microbiology)
  • Disease Progression
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Infectious (drug therapy, etiology)
  • Pseudomonas Infections (drug therapy, etiology)
  • Treatment Outcome
  • beta-Lactams (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: